Shizukaol F: a new structural type inhibitor of HIV-1 reverse transcriptase RNase H

( views:266, downloads:0 )
YANG Ying()
CAO Ying-li()
LIU Hai-yang()
YAN Huan()
GUO Ying()
Journal Title:
Acta Pharmaceutica Sinica
Volume 47, Issue 08, 2012
Key Word:


  • [1]Lu XF,Chen ZW.The development of anti-HIV-1 drugs[J].Acta Pharm Sin(药学学报),2010,45:165-176.
  • [2]Mbuagbaw LCE,Irlam JH,Spaulding A,et al.Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-na(i)ve individuals[J].Cochrane Database Syst Rev,2010,12:CD004246.
  • [3]Senise JF,Castelo A,Martinez M.Current treatment strategies,complications and considerations for the use of HIV antiretroviral therapy during pregnancy[J].AIDS Rev,2011,13:198-213.
  • [4]Peletskaya EN,Kogon AA,Tuske S,et al.Nonnucleoside inhibitor binding affects the interactions of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase with DNA[J].J Virol,2004,78:3387-3397.
  • [5]De Clercq E.Antiviral drugs in current clinical use[J].J Clin Virol,2004,30:115-133.
  • [6]Davies JF,Hostomska Z,Hostomsky Z,et al.Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase[J].Science,1991,252:88-95.
  • [7]Purohit V,Balakrishnan M,Kim B,et al.Evidence that HIV-1 reverse transcriptase employs the DNA 3' end-directed primary/secondary RNase H cleavage mechanism during synthesis and strand transfer[J].J Biol Chem,2005,280:40534-40543.
  • [8]Chung S,Wendeler M,Rausch JW,et al.Structure-activity analysis of vinylogous urea inhibitors of human immunodeficiency virus-encoded ribonuclease H[J].Antimicrob Agents Chemother,2010,54:3913-3921.
  • [9]Kawabata J,Fukushi E,Mizutani J.Sesquiterpene dimmers from Chloranthus japonicus[J].Phytochemistry,1995,39:121-125.
  • [10]Fang PL,Cao YL,Yan H,et al.Lindenane disesquiterpenoids with anti-HIV-1 activity from Chloranthus japonicus[J].J Nat Prod,2011,74:1408-1413.
  • [11]Cao YL,Guo Y.Screening of HIV-1 replication inhibitors by using pseudotyped virus system[J].Acta Pharm Sin (药学学报),2008,43:253-258.
  • [12]Capalbo G,Müller-Kuller T,Dietrich U,et al.Inhibition of HIV-1 replication by small interfering RNAs directed against Glioma Pathogenesis Related Protein (GIiPR) expression[J].Retrovirology,2010,7:26.
  • [13]Suzuki Y,Misawa N,Sato C,et al.Quantitative analysis of human immuno-deficiency virus type 1 DNA dynamics by real-time PCR:integration efficiency in stimulated and unstimulated peripheral blood mononuclear cells[J].Virus Genes,2003,27:177-188.
  • [14]Mbisa JL,Delviks-Frankenberry KA,Thomas JA,et al.Real-time PCR analysis of HIV-1 replication post-entry events[J].Methods Mol Biol,2008,485:55-72.
  • [15]Klumpp K,Hang JQ,Rajendran S,et al.Two-metal ion mechanism of RNA cleavage by HIV RNase H and mechanism-based design of selective HIV RNase H inhibitors[J].Nucl Acids Res,2003,31:6852-6859.
  • [16]Warren K,Warrilow D,Meredith L,et al.Reverse transcriptase and cellular factors:regulators of HIV-1 reverse transcription[J].Viruses,2009,1:873-894.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615